Henry T. Lynch | Academic Influence

Q: What Schools Are Affiliated With Henry T. Lynch

Henry T. Lynch is affiliated with the following schools: University of Denver, Institute of Cancer Research, Pomeranian Medical University in Szczecin, University of Texas at Austin, University of Toronto, Medical University of Vienna, University of Oklahoma, University of Cambridge, University of Texas Medical Branch, Creighton University

Why Is Henry T. Lynch Influential?

According to Wikipedia, Henry Thompson Lynch was an American physician noted for his discovery of familial susceptibility to certain kinds of cancer and his research into genetic links to cancer. He is sometimes described as "the father of hereditary cancer detection and prevention" or the "father of cancer genetics", although Lynch himself said that title should go to the early 20th century pathologist Aldred Scott Warthin.

Henry T. Lynch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (2778)
Identification of the breast cancer susceptibility gene BRCA2 (2597)
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. (2350)
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer (2279)
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) (2000)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. (1416)
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. (1130)
Identification of the breast cancer susceptibility gene BRCA2 (1027)
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients (958)
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. (953)
Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians (869)
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. (829)
Hereditary colorectal cancer. (813)
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. (793)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial (783)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (735)
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. (697)
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. (665)
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. (652)
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. (647)
Genetic susceptibility to non-polyposis colorectal cancer (642)
Alleles of the APC gene: An attenuated form of familial polyposis (603)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. (595)
Hereditary Colorectal Cancer (557)
Genetic instability of microsatellites in endometrial carcinoma. (556)
Extracolonic cancer in hereditary nonpolyposis colorectal cancer (549)
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study (544)
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome (514)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. (504)
Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review (487)
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. (470)
Hereditary factors in cancer. Study of two large midwestern kindreds. (462)
Colorectal cancer (462)
Familial gastric cancer: overview and guidelines for management* (459)
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. (445)
Milestones of Lynch syndrome: 1895–2015 (444)
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. (440)
Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma (430)
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. (427)
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer (417)
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (391)
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. (390)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. (386)
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource (378)
Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia (374)
Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type (362)
Cancer family “G” revisited: 1895‐1970 (358)
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (356)
GENETIC SUSCEPTIBILITY TO NONPOLYPOSIS COLORECTAL CANCER (335)
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability (333)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (325)
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. (323)
Gynecologic Cancer as a “Sentinel Cancer” for Women With Hereditary Nonpolyposis Colorectal Cancer Syndrome (320)
Familial atypical multiple mole-melanoma syndrome. (320)
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. (311)
Advances in counselling and surveillance of patients at risk for pancreatic cancer (303)
Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation (299)
The International Collaborative Group on HNPCC. (286)
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. (278)
Conversion of diploidy to haploidy (271)
Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer (269)
Genetic testing in families with hereditary nonpolyposis colon cancer. (268)
E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer (267)
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update (267)
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. (267)
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. (267)
Salpingo-Oophorectomy and the Risk Of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation (264)
Pathologic features of endometrial carcinoma associated with HNPCC (262)
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. (256)
Attenuated familial adenomatous polyposis (AFAP) a phenotypically and genotypically distinctive variant of FAP (254)
Distinguishing right from left colon by the pattern of gene expression. (251)
Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. (250)
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members (246)
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations (242)
Familial pancreatic cancer: a review. (236)
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. (231)
The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. (230)
An update of HNPCC (Lynch syndrome). (229)
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. (229)
The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. (229)
A descriptive study of BRCA1 testing and reactions to disclosure of test results (225)
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families (224)
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. (223)
Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome) (222)
Gastric cancer: New genetic developments (221)
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis (218)
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. (218)
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus (217)
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. (215)
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study (210)
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. (208)
Pathology of hereditary non-polyposis colorectal cancer. (208)
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. (206)
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management (199)
Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). (198)
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. (197)
Prophylactic oophorectomy in inherited breast/ovarian cancer families. (197)
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management (192)
Tritiated Thymidine (φp,φh) Labeling Distribution as a Marker for Hereditary Predisposition to Colon Cancer (188)
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (185)
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. (181)
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. (181)
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers (180)
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. (175)
A polymorphic stop codon in BRCA2 (174)
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers (174)
Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. (173)
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications (170)
Curcumin: An age-old anti-inflammatory and anti-neoplastic agent (167)
Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management (166)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (159)
Systemic cancer and the FAMMM syndrome. (158)
Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. (156)
GermlineSMAD4 orBMPRIA mutations and phenotype of juvenile polyposis (153)
Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome (153)
Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. (152)
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies (152)
Natural history of hereditary cancer of the breast and colon (149)
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. (149)
Hereditary non-polyposis colorectal cancer (146)
Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma (143)
Familial association of breast/ovarian carcinoma (140)
A genome wide linkage search for breast cancer susceptibility genes (139)
Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma (139)
Cancer risk in mismatch repair gene mutation carriers (137)
The tumor spectrum in HNPCC. (136)
Muir‐Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome (133)
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. (130)
Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. (129)
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? (128)
Pancreatic Cancer Genetic Epidemiology Consortium (127)
The influence of psychological distress on use of genetic testing for cancer risk (127)
Colorectal cancer in rural Nebraska. (127)
Hereditary Ovarian Cancer: A Clinicopathological Study (125)
Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II) (125)
Genetic predisposition to breast cancer (124)
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. (124)
Hereditary diffuse gastric cancer: association with lobular breast cancer (123)
Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline (123)
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC) (123)
Hereditary nonpolyposis colorectal cancer. (122)
Mammary Gland Architecture as a Determining Factor in the Susceptibility of the Human Breast to Cancer (122)
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma (122)
The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. (120)
Family history of colorectal cancer as a marker of potential malignancy within a screening program (120)
The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. (120)
Role of heredity in multiple primary cancer (119)
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (117)
Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa. (116)
Tumour spectrum in the FAMMM syndrome. (116)
Hereditary diffuse gastric cancer (116)
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study (115)
Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. (115)
Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? (113)
Flat adenomas in a colon cancer-prone kindred. (112)
Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population (112)
A BRCA1 nonsense mutation causes exon skipping. (112)
Pancreatic cancer and the FAMMM syndrome (112)
Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. (111)
Tumor variation in families with breast cancer. (111)
Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. (111)
Who should be sent for genetic testing in hereditary colorectal cancer syndromes? (110)
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. (110)
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. (109)
Genetics and ovarian carcinoma. (109)
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. (108)
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. (108)
Pancreatic Cancer and the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome (108)
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer (108)
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. (108)
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. (107)
Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II) (107)
Hereditary flat adenoma syndrome: A variant of familial adenomatous polyposis? (107)
Paravertebral malignant rhabdoid tumor in infancy in vitro studies of a familial tumor (106)
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. (105)
Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancer (104)
Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome (104)
Heredity and adenocarcinoma of the colon. (104)
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms–mismatch repair (MAPP‐MMR) (104)
Rectal cancer after prolonged sulindac chemoprevention. A case report (103)
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium (103)
Cancer variation associated with the position of the mutation in the BRCA2 gene (103)
Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis. (102)
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. (102)
Multicenter Experience with Upper Gastrointestinal Polyps in Pediatric Patients with Familial Adenomatous Polyposis (101)
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (101)
Lynch syndrome: genetics, natural history, genetic counseling, and prevention. (101)
Colorectal adenomas in the Lynch syndromes. Results of a colonoscopy screening program. (101)
Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. (101)
Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families (100)
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 (100)
Genetic linkage analysis in familial breast and ovarian cancer (100)
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. (99)
Hereditary breast cancer. (98)
SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers (96)
Parental communication of BRCA1/2 genetic test results to children. (96)
Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles (96)
MYC Is Amplified in BRCA1-Associated Breast Cancers (95)
Hereditary proximal colonic cancer (95)
The Lynch syndrome II and urological malignancies. (95)
Familial multiple myeloma: a family study and review of the literature. (94)
Comparison of Extended Colectomy and Limited Resection in Patients With Lynch Syndrome (93)
Cumulative incidence of colorectal and extracolonic cancers in mlh1 and msh2 mutation carriers of hereditary nonpolyposis colorectal cancer (92)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. (92)
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (91)
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. (91)
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case–control study (90)
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (90)
BRCA1 and pancreatic cancer: pedigree findings and their causal relationships. (90)
Lynch syndrome in the 21st century: clinical perspectives. (88)
Family history in an oncology clinic. Implications for cancer genetics. (88)
Epidemiologic characteristics of the flat adenoma of muto (88)
Hereditary Breast Cancer: Part I. Diagnosing Hereditary Breast Cancer Syndromes (87)
Colon cancer genetics (87)
Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC‐like families: Problems in diagnosis, surveillance, and management (87)
A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. (87)
Pathology and heredity of breast cancer in younger women. (85)
Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome (85)
Molecular pathology of primary and metastatic ductal pancreatic lesions (84)
Heredity and malignant melanoma: implications for early cancer detection. (83)
NEW CUTANEOUS PHENOTYPE IN FAMILIAL MALIGNANT MELANOMA (82)
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome (82)
Brain tumors in individuals with familial adenomatous polyposis (81)
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers (81)
Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study (81)
Carcinoma of the breast and ovary in three families. (81)
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers (81)
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers (80)
Genetics, biomarkers, and control of breast cancer: a review. (80)
Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls. (80)
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. (79)
Hereditary ovarian cancer. Heterogeneity in age at diagnosis (79)
Hereditary Pancreatic Cancer (79)
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. (79)
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. (79)
History and molecular genetics of Lynch syndrome in family G: a century later. (78)
“Organic brain syndrome” secondary to 5-fluorouracil toxicity (78)
Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model (77)
Epidemiology of pancreatic cancer: an overview. (77)
Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. (76)
Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). (76)
Genetics of Colonic Cancer (76)
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation (76)
The influence of psychological distress on use of genetic testing for cancer risk. (75)
What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation (75)
An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. (75)
Surveillance and Management of Patients at High Genetic Risk for Ovarian Carcinoma (74)
The cancer syndrome: A status report (74)
Molecular Genetics and Clinical-Pathology Features of Hereditary Nonpolyposis Colorectal Carcinoma (Lynch Syndrome) (73)
Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies (73)
The CYP1A2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA1 Mutation Carriers (72)
Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? (72)
Identifying hereditary nonpolyposis colorectal cancer. (72)
Hereditary cancer in adults. (72)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers (72)
New phenotypic aspects in a family with lynch syndrome II (71)
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers (70)
Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus. (70)
The History of Lynch Syndrome (69)
Familial atypical multiple mole melanoma (FAMMM) syndrome: genetic heterogeneity and malignant melanoma. (69)
Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers (68)
Upper urinary tract carcinoma in Lynch syndrome cases. (67)
Surfaced-Enhanced Laser Desorption/Ionization Time-of-Flight (SELDI-TOF) Differentiation of Serum Protein Profiles of BRCA-1 and Sporadic Breast Cancer (66)
Familial ovarian carcinoma. Clinical nuances. (65)
Familial association of carcinoma of the breast and ovary. (65)
Inherited genetic susceptibility to multiple myeloma (65)
Genomic Sequencing of DPC4 in the Analysis of Familial Pancreatic Carcinoma (64)
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) (64)
Primary choroidal and cutaneous melanomas, bilateral choroidal melanomas, and familial occurrence of melanomas. (64)
Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. (63)
Family information service and hereditary cancer (63)
A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred (63)
Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells. (63)
Inherited predisposition to cancer: A historical overview (62)
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. (62)
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy (61)
Hereditary nonpolyposis colorectal cancer: preventive management. (61)
Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations (61)
Current Hypotheses on How Microsatellite Instability Leads to Enhanced Survival of Lynch Syndrome Patients (61)
BRCA1 and BRCA2 hereditary breast carcinoma phenotypes (61)
Genetics and smoking‐associated cancers. A study of 485 families (61)
Familial Breast Cancer: Risk to the Contralateral Breast (61)
Segregation analysis of hereditary nonpolyposis colorectal cancer (60)
Screening adherence in BRCA1/2 families is associated with primary physicians' behavior (60)
Surveillance in Lynch syndrome: how aggressive? (60)
Hereditary Factors in Carcinoma (60)
ENDOMETRIAL CARCINOMA: MULTIPLE PRIMARY MALIGNANCIES, CONSTITUTIONAL FACTORS, AND HEREDITY (60)
Phenotypic heterogeneity in multiple myeloma families. (60)
Hereditary nonpolyposis colorectal cancer (HNPCC) (60)
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. (60)
Adenocarcinoma of the small bowel in Lynch syndrome II (60)
Frequency of hereditary nonpolyposis colorectal carcinoma (Lynch syndromes I and II). (60)
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers (60)
In-situ breast cancer and BRCA 1 (59)
Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines (59)
Breast cancer genetics in an oncology clinic: 328 consecutive patients. (59)
Rectal cancer in FAP patient after sulindac (58)
Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion (58)
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (58)
Multiple primary cancers and prolonged survival: Familial colonic and endometrial cancers (57)
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. (57)
Characterization of the neoplastic phenotype in the familial atypical multiple‐mole melanoma–pancreatic carcinoma syndrome (57)
Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. (57)
Classification of familial adenomatous polyposis: a diagnostic nightmare. (56)
Phenotypic variation in colorectal adenoma/cancer expression in two families. Hereditary flat adenoma syndrome (56)
Increasing incidence of breast cancer in family with BRCA1 mutation (55)
Brca2 hereditary breast cancer pathophenotype (55)
Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. (55)
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation (54)
Genetic Epidemiology of Cancer (54)
Lynch Syndrome: History and Current Status (54)
The cancer-family syndrome: A pragmatic basis for syndrome identification (54)
Genetics and Breast Cancer (53)
Hereditary pancreatic adenocarcinoma. A clinical perspective. (53)
Familial cancer syndromes: A survey (53)
Klinefelter syndrome and cancer. A family study. (53)
Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). (53)
Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene. (52)
Suspected hereditary nonpolyposis colorectal cancer (52)
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers (52)
The cancer family syndrome and cancer control. (52)
Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. (52)
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. (52)
Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers (52)
The surgeon, genetics, and cancer control: the Cancer Family Syndrome. (52)
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers (52)
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells (51)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation (51)
A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. (51)
Ehlers-Danlos syndrome and "congenital" arteriovenous fistulae. A clinicopathologic study of a family. (51)
Hereditary ovarian cancer: Heterogeneity in age at onset (50)
TGFBR1*6A may contribute to hereditary colorectal cancer. (50)
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (50)
An update on Lynch syndrome. (50)
Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family hostory of ovarian cancer (50)
Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population (49)
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers (49)
HEREDITY AND MULTIPLE PRIMARY MALIGNANT NEOPLASMS: SIX CANCER FAMILIES (49)
Secondary male hypogonadism and congenital ichthyosis: association of two rare genetic diseases. (48)
Tumor variation in the cancer family syndrome: ovarian cancer. (48)
Management of hereditary site-specific colon cancer. (48)
Smoking and the risk of breast cancer among carriers of BRCA mutations (48)
Family studies of malignant melanoma and associated cancer. (47)
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study (47)
Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer (47)
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. (47)
PMS2 monoallelic mutation carriers: the known unknown (47)
Genetics and pancreatic cancer. (47)
Familial mesothelioma: review and family study. (46)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (46)
Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study (46)
Heredity and intraocular malignant melanoma: Study of two families and review of forty‐five cases (46)
Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome (46)
Genetic factors in families with combined gastrointestinal and breast cancer. (45)
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. (45)
Hereditary nonpolyposis colorectal cancer in a Navajo Indian family. (45)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (45)
Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis. (45)
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers. (45)
Hereditary ovarian and breast cancer: what have we learned? (45)
What the physician needs to know about Lynch syndrome: an update. (45)
A century of progress in hereditary nonpolyposis colorectal cancer (lynch syndrome) (44)
The genetic epidemiology of male breast carcinoma (44)
Novel germline p16INK4 allele (Asp145Cys) in a family with multiple pancreatic carcinomas (44)
Failure to diagnose hereditary colorectal cancer and its medicolegal implications (44)
Hereditary cancer: Ascertainment and management (44)
Oral Contraceptives and the Risk of Breast Cancer in BRCA 1 and BRCA 2 Mutation Carriers (44)
Prolonged survival as a component of a hereditary breast and nonpolyposis colon cancer. (43)
Plasma hormone profiles of young women at risk for familial breast cancer. (43)
Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature (43)
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. (43)
Xeroderma pigmentosum, malignant melanoma, and congenital ichthyosis. A family study. (43)
A Comparison of Bilateral Breast Cancers in BRCA Carriers (43)
Familial pancreatic carcinoma in Jews (43)
Hereditary Factors in Adiposis Dolorosa (Dercum's Disease). (42)
Patent ductus arteriosus. Study of two families. (42)
Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. (42)
Familial colon cancer in the Tel‐Aviv area and the influence of ethnic origin (42)
Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer (42)
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration (41)
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. (41)
Genetics and colon cancer. (41)
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. (40)
Familial Pancreatic Cancer: A Family Study (40)
Cancer control in xeroderma pigmentosum. (40)
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland (40)
Surveillance/management of an obligate gene carrier: the cancer family syndrome. (39)
Germline splicing mutations of CDKN2A predispose to melanoma (39)
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. (39)
Origins and prevalence of the American Founder Mutation of MSH2. (39)
Hereditary colorectal cancer-part II. (39)
Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer. (38)
Rectal epithelial cell proliferation in a group of young adults. Influence of age and genetic risk for colon cancer (38)
A familial aggregation of pancreatic cancer. An in vitro study. (38)
Laryngeal carcinoma in a lynch syndrome II kindred (38)
Hereditary pancreatic cancer: a clinical perspective. (38)
Association of soft tissue sarcoma, leukemia, and brain tumors in families affected with breast cancer. (38)
Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome. (38)
Low urinary estrogen glucuronides in women at risk for familial breast cancer. (37)
Celecoxib Treatment Alters the Gene Expression Profile of Normal Colonic Mucosa (37)
Prevalence of Barrett Esophagus in First-Degree Relatives of Patients With Esophageal Adenocarcinoma (37)
Familial excess of cancer of the ovary and other anatomic sites. (37)
Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. (37)
Breast cancer family history as a risk factor for early onset breast cancer (37)
Familial pancreatic cancer (Part 1): Genetic pathology review. (37)
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30 (37)
Early age of onset in familial breast cancer. Genetic and cancer control implications. (37)
Screening for familial and hereditary prostate cancer (37)
Psychological aspects of monitoring high risk women for breast cancer (36)
Prostate carcinoma and multiple primary malignancies: Study of a family and 109 consecutive prostate cancer patients (36)
Familial factors in bladder carcinoma. (36)
The sarcoma, breast cancer, lung cancer, and adrenocortical carcinoma syndrome revisited. Childhood cancer. (36)
Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Online. (36)
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. (36)
Communication of BRCA1/2 test results in hereditary breast cancer families (36)
Histology of BRCA1-associated ovarian tumours (35)
Tritiated thymidine (phi p, phi h) labeling distribution as a marker for hereditary predisposition to colon cancer. (35)
AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study (35)
The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. (35)
A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. (35)
Colorectal cancer in hereditary breast cancer kindreds (35)
Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer (34)
Hereditary colon cancer: Polyposis and nonpolyposis variants (34)
Genetic factors and colorectal cancer in Ashkenazi Jews (34)
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. (34)
Hereditary ovarian cancer. Pedigree studies, Part II. (34)
Hereditary colon cancer syndromes. (34)
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (34)
Analysis of CHEK2 gene for ovarian cancer susceptibility. (34)
Familial breast cancer and its recognition in an oncology clinic (33)
Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. (33)
Genetics of Hodgkin's and non-Hodgkin's lymphoma: a review. (33)
Tumor variation in three extended Lynch syndrome II kindreds. (33)
Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer. (33)
Genetic counseling in a navajo hereditary nonpolyposis colorectal cancer kindred (32)
The Lynch syndromes (32)
CHEK2 mutation and hereditary breast cancer. (32)
Clinical/genetic features in hereditary breast cancer (32)
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies (32)
Organization of actin‐containing cables in cultured skin fibroblasts from individuals at high risk of colon cancer (32)
Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. (32)
Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability. (32)
Inherited, familial and sporadic primary open-angle glaucoma. (31)
Hereditary factors in pancreatic cancer. (31)
Differential diagnosis of the cancer family syndrome. (31)
The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): A classic obligation in preventive medicine. (31)
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. (31)
Hereditary colon cancer--part I. (31)
Cancer Genetics in the New Era of Molecular Biology (31)
25 years of HNPCC. (30)
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? (30)
Muir-Torre syndrome: Heterogeneity, natural history, diagnosis, and management (30)
Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas (30)
Molecular screening for the Lynch syndrome--better than family history? (30)
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update (30)
Hereditary ovarian carcinoma. Biomarker studies (29)
Familial risk and cancer control. (29)
International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers (29)
Genetic predictability in breast cancer risk. Surgical implications. (29)
Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. (29)
Familial breast-ovarian cancer locus on chromosome 17q12-q23 (29)
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking. (28)
Automated detection of hereditary syndromes using data mining. (28)
Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma. (28)
Hereditary carcinoma of the ovary and associated cancers: a study of two families. (28)
Linkage analysis of chromosome 4 in families with familial pancreatic cancer (28)
BRCA1 and BRCA2 families and the risk of skin cancer (28)
Hormone Therapy and the Risk of Breast Cancer in BRCA 1 Mutation Carriers (28)
Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. (28)
Familial cancer in an oncology clinic (28)
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 (27)
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene (27)
Hereditary progressive atrioventricular conduction defect. (27)
Phenotypic variation in the familial atypical multiple mole-melanoma syndrome (FAMMM). (27)
Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily. (27)
Hl‐a in cancer family “n” (27)
Cancer in Jews: introduction and overview (27)
Mutation of an mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer. (27)
The Cancer-Family Syndrome (26)
Hereditary Progressive Atrioventricular Conduction Defect: A New Syndrome? (26)
Hereditary Breast Cancer: Practical Pursuit for Clinical Translation (26)
Genetic counseling for hereditary cancer. (26)
Prognosis of BRCA1 hereditary breast cancer (26)
Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM. (26)
Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome. (26)
Hereditary breast cancer and family cancer syndromes (25)
The FAMMM Syndrome: Epidemiology and Surveillance Strategies (25)
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review (25)
Dynamic genetic counseling for clinicians (25)
Can Unknown Predisposition in Familial Breast Cancer be Family‐Specific? (25)
Gynecologic cancer clues to Lynch syndrome II diagnosis: a family report. (24)
The impact of genetic counseling upon the family milieu. (24)
Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus. (24)
Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle. (24)
Hereditary atrial septal defect. Update of a large kindred. (24)
Variable gastrointestinal and urologic cancers in a lynch syndrome II kindred (24)
Familial cancer prevalence spanning eight years. Family N. (24)
SBLA syndrome revisited. (24)
Minimal genetic findings and their cancer control implications. A family with the cancer family syndrome. (24)
Torre's syndrome as phenotypic expression of cancer family syndrome. (23)
Predominance of brain tumors in an extended Li‐Fraumeni (SBLA) kindred, including a case of Sturge‐Weber syndrome (23)
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment (23)
Germline RAP80 mutations and susceptibility to breast cancer (23)
Recognition of the cancer family syndrome. (23)
Obstructive Lung Disease in Hereditary α1-Antitrypsin Deficiency (23)
Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review (23)
Cancer and the family history trail. (23)
Sex hormone regulation of survivin gene expression. (23)
The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study (22)
Familial breast cancer in a normal population (22)
Familial occurrences of a variety of premalignant diseases and uncommon malignant neoplasms (22)
Familial Adenomatous Polyposis and Extracolonic Cancer (22)
Survival in hereditary breast and colon cancer. (22)
The evolution of colorectal cancer genetics-Part 1: from discovery to practice. (22)
BRCA1 and BRCA2 Mutations in Breast and Ovarian Cancer Syndrome: Reflection on the Creighton University Historical Series of High Risk Families (22)
The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. (22)
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study (21)
Familial bladder cancer in an oncology clinic. (21)
Colorectal Cancer and the Muir-Torre Syndrome in a Gypsy Family: A Review (21)
Hereditary Colorectal Cancer Review: Colonic Polyposis and Nonpolyposis Colonic Cancer (Lynch Syndrome I and II) (21)
Genetics, etiology, and human cancer. (21)
Prophylactic mastectomy: obstacles and benefits. (21)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (21)
Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies. (21)
Hereditary Breast Cancer: Part II. Management of Hereditary Breast Cancer: Implications of Molecular Genetics and Pathology (21)
Management of familial breast cancer. II. Case reports, pedigrees, genetic counseling, and team concept. (21)
Prophylactic surgery to reduce the risk of gynecologic cancers in the lynch syndrome (20)
Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome (20)
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer (20)
Heredity and Gastrointestinal Tract Cancer (20)
Familial polyposis coli: heterogeneous polyp expression in 2 kindreds. (20)
Familial Hodgkin's disease and associated cancer. A Clinical‐Pathologic Study (20)
Childhood cancer and the SBLA syndrome. (20)
Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge (20)
Histologic Features of Hereditary Nonpolyposis Colorectal Carcinoma (20)
Familial cancer: implications for surgical management of high-risk patients. (20)
Leser-Trelat sign in mother and daughter with breast cancer. (20)
HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management - a Review (20)
AFAP: variety is the spice of life (19)
FAMILIAL COEXISTENCE OF DIABETES MELLITUS, HYPERLIPEMIA, SHORT STATURE, AND HYPOGONADISM (19)
Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer (19)
Breast cancer, genetics, and age at first pregnancy. (19)
Familial peritoneal ovarian carcinomatosis: a new clinical entity? (19)
Management of familial breast cancer. I. Biostatistical-genetic aspects and their limitations as derived from a familial breast cancer resource. (19)
E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma. (19)
The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. (19)
Skin, heredity, and cancer (19)
Practical genetics of colorectal cancer. (19)
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. (19)
Genetic/epidemiological findings in a study of smoking-associated tumors. (19)
Integration of family history and medical management of patients with hereditary cancers (19)
Cancer of the colon: socioeconomic variables in a community. (19)
Reassignment of a cancer family syndrome gene to chromosome 18. (19)
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (19)
Skin, heredity, and cancer. (19)
Natural history and age at onset of hereditary breast cancer (19)
Medical genetic study of eight pancreatic cancer-prone families. (19)
Strategies for Control (18)
Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. (18)
Delay: a deterrent to cancer detection. (18)
Communication and technology in genetic counseling for familial cancer (18)
Xeroderma pigmentosum. Complementation group C and malignant melanoma. (18)
Familial heterogeneity of colon cancer risk (18)
A Founder Mutation of the MSH 2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States (18)
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): a common genotype linked to oncogenes? (18)
Diagnosing Lynch syndrome: is the answer in the mouth? (17)
Familial Adenomatous Polyposis in Children Younger than Age Ten Years: A Multidisciplinary Clinic Experience (17)
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. (17)
Hereditary chronic lymphocytic leukemia: an extended family study and literature review. (17)
Programmed death 1 (PD-1) lymphocytes and ligand (PD-L1) in colorectal cancer and their relationship to microsatellite instability status. (17)
A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. (17)
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study (17)
Hereditary gastrointestinal cancer syndromes. (17)
Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers (17)
Familial aggregation of carcinoma of the endometrium. (17)
Dermatoglyphic peculiarities in members of a high-cancer-risk kindred. (16)
THE "WHOLE FAMILY" CONCEPT IN CLINICAL GENETICS. (16)
Increased in vitro tetraploidy in dermal monolayer cultures derived from normals. (16)
Immunology and the Lynch syndrome. (16)
Familial risk for neuroendocrine tumors (16)
Malignant Congenital Osteopetrosis Resulting from a Consanguineous Marriage (16)
Clinical implications of advances in the molecular genetics of colorectal cancer. (16)
Chromosome instability and the FAMMM syndrome. (16)
The Cutaneous Evolution of Nevi in a Patient with Familial, Atypical, Multiple‐mole Melanoma Syndrome (16)
Delay factors in detection of cancer of the penis. (16)
Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity (16)
CONGENITAL HYPERTROPHY OF RETINAL PIGMENT EPITHELIUM IN NON-GARDNER'S POLYPOSIS KINDREDS (16)
National Institutes of Health consensus report on precursors to malignant melanoma. A difference in opinion. (16)
Colorectal Cancer and the Muir-Torre Syndrome in a Gypsy Family: A Review (16)
American founder mutation for Lynch syndrome (16)
Muir-Torre syndrome and defective DNA mismatch repair genes. (15)
Cancer risk assessment in a hereditary cancer prevention clinic and its first year's experience (15)
Genotype/phenotype of familial pancreatic cancer. (15)
Current status of prophylactic surgery for hereditary breast and gynecologic cancers (15)
Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis (15)
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers (15)
Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. (15)
A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family. (15)
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers (15)
Multiple Primary Cancer, Including Transitional Cell Carcinoma of the Upper Uroepithelial Tract in a Multigeneration HNPCC Family: Molecular Genetic, Diagnostic, and Management Implications (15)
Plasma lipids, lipoproteins, and familial breast cancer. (15)
Early age at breast cancer onset--a genetic and oncologic perspective. (15)
Principles of Molecular Diagnostics and Personalized Cancer Medicine (15)
"Cancer Families:" Adenocarcinomas (Endometrial and Colon Carcinoma) and Multiple Primary Malignant Neoplasms (14)
Desmoid tumors: genotype-phenotype differences in familial adenomatous polyposis--a nosological dilemma. (14)
Phenotypic variation in hereditary adenomatosis: Unusual tumor spectrum (14)
Cancer genes, multiple primary cancer, and von Hippel-Lindau disease. (14)
The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. (14)
Genetic counselling and hereditary breast/ ovarian cancer (14)
Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage. (14)
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register (14)
Genetic heterogeneity and familial carcinoma of the breast. (14)
Hereditary ovarian cancer. Heterogeneity in age at diagnosis. (14)
A new approach to cancer screening and education. (14)
Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer. (14)
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. (14)
Breast cancer genetics: family history, heterogeneity, molecular genetic diagnosis, and genetic counselling. (14)
Genetic Predisposition to Cancer (14)
Role of prophylactic colectomy in Lynch syndrome. (14)
Heterogeneity and natural history of hereditary breast cancer. Surgical implications. (13)
Inherited Susceptibility to Cancer: Clinical, Predictive and Ethical Perspectives (13)
Aldred scott warthin, m.d., ph.d. (1866‐1931) (13)
Colorectal cancer in a nuclear family (13)
Excess of extracolonic non‐endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1 (13)
The cancer family syndrome: a status report. (13)
Screening for GermLine Rearrangements and Regulatory Mutations in BRCA 1 Led to the Identification of Four New Deletions 1 (13)
Hereditary malignant melanoma: a unifying etiologic hypothesis. (13)
Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control. (13)
Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention (13)
Tumor infiltrating lymphocytes (TILs): Lessons learned in 30 years of study (13)
History of the International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer (13)
Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation. (13)
Major hereditary gastrointestinal cancer syndromes: a narrative review. (13)
VITAMIN D-INTOXICATED PATIENT WITH HYPOPARATHYROIDISM; HYPERCALCEMIA, ACUTE CEREBELLAR ATAXIA, AND EEG CHANGES: MAGNESIUM SULFATE THERAPY. (13)
Clinical, genetic, and biostatistical progress in the cancer family syndrome. (13)
EPCAM deletions, Lynch syndrome, and cancer risk. (13)
Familial factors and genetic predisposition to cancer: population studies. (13)
Cancer genetics in women (13)
The muir-torre syndrome: A variant of hereditary nonpolyposis colorectal cancer syndrome (13)
Genetic diagnosis of lynch syndrome II in an extended colorectal cancer‐prone family (13)
Hereditary nonpolyposis colorectal cancer (lynch syndrome II) in Uruguay (12)
Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers (12)
Heredity and Endometrial Carcinoma (12)
Family History of Cancer (12)
Morphological and morphometric measurements in colorectal mucosa of subjects at increased risk for colonic neoplasia. (12)
A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers. (12)
Familial multiple myeloma. (12)
Breast cancer genetics and cancer control. Tumor association. (12)
A family study of adenocarcinoma of the colon and multiple primary cancer. (12)
Cancer-associated genodermatoses (12)
Genetic and immunopathological findings in a lymphoma family. (12)
Cancer control problems in the lynch syndromes (12)
PSYCHODYNAMICS OF EARLY HEREDITARY DEATHS. ROLE OF THE MEDICAL GENETICS COUNSELOR. (12)
Diethylstilbestrol, genetics, teratogenesis, and tumor spectrum in humans. (11)
The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first‐degree relative with breast cancer (11)
The CYP 1 A 2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA 1 Mutation Carriers (11)
Hereditary ovarian carcinoma. (11)
Skin, heredity, and malignant neoplasms (11)
Genetic counseling and HNPCC. (11)
Psychodynamics in a chronic debilitating hereditary disease. Myotonia dystrophica. (11)
Wilms' tumor and congenital heart disease: report of a case and family. (11)
Aspirin Use is Associated with Lower Prostate Cancer Risk in Male Carriers of BRCA Mutations (11)
Anticipation in familial Hodgkin's lymphoma (11)
PCCR: Pancreatic Cancer Collaborative Registry (11)
Subjective perspective of a family with Huntington's chorea. Implications for genetic counseling. (11)
Familial sarcoma: challenging pedigrees. (11)
Epidemiology and Risk Factors (11)
Extremely early onset hereditary breast cancer (HBC): surveillance/management implications. (11)
Making Sense of Missense in Lynch Syndrome: The Clinical Perspective (11)
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry (10)
Familial cancer syndromes: a survey (10)
Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (10)
Neuroendocrine-Type Prostatic Adenocarcinoma With Microsatellite Instability in a Patient With Lynch Syndrome (10)
Genetic predictability and minimal cancer clues in lynch syndrome II (10)
Genetic and communicable effects on carcinoembryonic antigen expressivity in the cancer family syndrome. (10)
Gynecological malignancy as a "sentinel cancer" for women with HNPCC. (10)
International directory of genetic services. (10)
Microsatellite instability, clinical implications, and new methodologies. (10)
Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers (10)
Survey of cancer genetics (10)
Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. (10)
Erratum: Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management (Cancer (2004) (100 (53-64)) (10)
Genome instability in blood cells of a BRCA1+ breast cancer family (10)
The dermatologist, genetic counseling, and cancer-associated genodermatoses. (9)
Genetics, natural history, surveillance, management, and gene mapping in the Lynch syndrome. (9)
Genetic counseling in an extended attenauted familial adenomatous polyposis kindred. (9)
Initial Report of a Family Registry of Multiple Myeloma (9)
The family history and cancer control. Hereditary breast cancer. (9)
Dawning of the epigenetic era in hereditary cancer (9)
Using data mining to characterize DNA mutations by patient clinical features (9)
Familial atypical multiple mole melanoma syndrome (FAMMM) (9)
Hereditary progressive atrioventricular conduction defect. A new syndrome? (9)
Hereditary diffuse gastric cancer: lifesaving total gastrectomy for CDH1 mutation carriers (9)
The surgeon and colorectal cancer genetics. Case identification, surveillance, and management strategies. (9)
Clinical results using informatics to evaluate hereditary cancer risk. (9)
Population differences in familial adenomatous polyposis may be an expression of geographic differences in APC mutation pattern. (8)
Genetic factors in breast cancer: a survey. (8)
Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations (8)
Identification of high-risk pancreatic cancer-prone families. (8)
13 – Genetic Counseling and Cancer1 (8)
Diagnosis and management issues in pediatric patients with gastrointestinal polyps (8)
EARLY AGE OF ONSET AND FAMILIAL BREAST CANCER (8)
Phase II breast cancer chemoprevention trial of the third generation selective estrogen receptor modulator arzoxifene. (8)
Cancer concordance and the hypothesis of autosomal dominant transmission of cancer diathesis in a remarkable kindred. (8)
Age-of-onset heterogeneity in hereditary breast cancer: Minimal clues for diagnosis (8)
Anthropometric Measures and Risk of Ovarian Cancer Among BRCA1 and BRCA2 Mutation Carriers (8)
Considerations for Comprehensive Assessment of Genetic Predisposition in Familial Breast Cancer (8)
Family Information Service Participation Increases the Rates of Mutation Testing Among Members of Families with BRCA1/2 Mutations (8)
Familial adenomatous polyposis (8)
Carcinoembryonic antigen (CEA) in the cancer family syndrome (8)
Genetic analysis of human breast cancer: Literature review and description of family data in workshop (8)
E2F-4 mutation in hereditary non-polyposis colorectal cancer. (8)
Adenoma follow-up in at-risk Lynch syndrome family members. (8)
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? (8)
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers (8)
Breast carcinoma and delay in treatment. (8)
Molecular Analysis of the Retinoblastoma (Rb) Gene in Human Colorectal Carcinomas (7)
Cancer, heredity and genetic counseling. Xeroderma pigmentosum (7)
FAMILY CENTERED GENETIC COUNSELING: ROLE OF THE PHYSICIAN AND THE MEDICAL GENETICS CLINIC. (7)
The clinical use of genealogical techniques in cancer investigations: a questionnaire survey. (7)
HNPCC-Lynch syndrome and idiopathic inflammatory bowel disease. A hypothesis on sharing of genes. (7)
Endometrial Cancers in Mutation Carriers From Hereditary Breast Ovarian Cancer Syndrome Kindreds: Report From the Creighton University Hereditary Cancer Registry With Review of the Implications (7)
History of the International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer (7)
Sex differences in lung cancer incidence: a genetic model. (7)
The evolution of colorectal cancer genetics-Part 2: clinical implications and applications. (7)
Cancer family history and genetic testing: are malpractice adjudications waiting to happen? (7)
Multiphasic mobile cancer screening: A positive approach to early cancer detection and control (7)
Commentary on Almassalha et al., "The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer". (7)
Barrett’s esophagus in the patients with familial adenomatous polyposis (7)
Familial and Genetic Factors — New Evidence (7)
Modification of BRCA 1-and BRCA 2-associated Breast Cancer Risk by AIB 1 Genotype and Reproductive History 1 (7)
Recent Progress in the Genetic Epidemiology of Cancer (7)
A familial syndrome characterized by peculiar facies, small stature, chromosomal aberrations and aminoacriduria. (7)
Genetic counseling and cancer: implications for cancer control. (7)
Sessile Serrated Adenomas: Why Conventional Endoscopy Is Okay for Unconventional Polyps (7)
Genetic counseling in cleft lip and cleft palate. (7)
What is hereditary colon cancer? (7)
Familial breast cancer: risk to the contralateral breast. (7)
Colorectal cancer: Update on the clinical management of Lynch syndrome (7)
A note on "cancer-susceptible" and "cancer-resistant" genotypes: implications for cancer detection and research. (7)
Natural history of at-risk Lynch syndrome family members with respect to adenomas. (7)
Hereditary carcinoma of the ovary and associated cancers: A study of two families (7)
Etiology of carcinoma: genetic determinism. (7)
Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy (7)
SKIN CANCER DEVELOPING IN XERODERMA PIGMENTOSUM PATIENT RELAXING SUNLIGHT AVOIDANCE (7)
FAMILIAL INDICATIONS FOR PROPHYLACTIC SURGERY IN BREAST-CANCER-PRONE FAMILIES (7)
BRCA1, pathology, and survival. (7)
AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study (7)
Clinical nuances of Lynch syndromes I and II. (7)
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (7)
Cancer genetic problems: host-environmental considerations. (7)
Tetralogy of Fallot in two siblings. Associated anomalies of the head and neck in one child. (6)
Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer. (6)
Hereditary gynecologic cancer. (6)
Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers. (6)
Biomarkers, genetics and cancer (6)
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis (6)
Modification of BRCA 1-Associated Breast and Ovarian Cancer Risk by BRCA 1-Interacting Genes (6)
Effect of the third generation selective estrogen receptor modulator arzoxifene on mammographic breast density. (6)
Cancer in the Third World: Bangladesh 1980. (6)
Heredity and breast cancer: implications for cancer control. (6)
Familial hepatocellular carcinoma in an endemic area of Thailand. (6)
Cancer family history and genetic testing: are malpractice adjudications waiting to happen? (6)
Klippel-Feil syndrome and bicuspid aortic valve: report of a case. (6)
Flat cancers do develop in the polyp-free large intestine (6)
Genetic counseling and the physician. (6)
Genetic Variation in IGF 2 and HTRA 1 and Breast Cancer Risk among BRCA 1 and BRCA 2 Carriers (6)
Attitudes and delay in cancer detection (6)
Hereditary nonpolyposis colon cancer: (Lynch syndrome I and II). A challenge for the clinician. (6)
Survival data from a multiphasic mobile cancer detection unit. (6)
The identification and management of hereditary diffuse gastric cancer in a large Jordanian family (6)
Low serum IgA in a familial ovarian cancer aggregate. (6)
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers (6)
Genetics and smoking-associated cancers: 461 families (6)
PROXIMAL COLON CANCER IN FAMILIAL CARCINOMA OF THE COLON EXCLUSIVE OF FAMILIAL POLYPOSIS COLI (6)
Glioblastoma multiforme as initial internal malignancy in Muir-Torre syndrome (MTS) (6)
Psychodynamics in cancer detection: a patient with advanced cancer of the lip. (6)
[Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. (6)
Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer. (6)
Identification of an HNPCC family. (6)
alpha-L-fucosidase variant and lipid-associated sialic acid in hereditary ovarian cancer. (6)
Update on familial pancreatic cancer (6)
Genetics in urogenital cancer. (6)
Clinical selection of candidates for mutational testing for cancer susceptibility. (6)
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers. (5)
The surgeon, genetics, and malignant melanoma. (5)
Esophageal cancer in a midwestern community. (5)
Pathology and genetic markers of colorectal cancer in Lynch syndromes I and II (5)
Surgical Strategies for Management of the Lynch Syndromes (5)
Monitoring High Risk Women: Psychological Aspects (5)
Genetic factors in carcinoma. (5)
The colonoscopist and the Lynch syndromes. (5)
Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA 1 or BRCA 2 Mutations (5)
Endocrine profile in a patient with familial breast cancer. A case‐control study (5)
Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus. (5)
Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part I) (5)
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers. (5)
Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature. (5)
Genetic counseling, familial breast cancer, and the surgeon's responsibility. (5)
A hereditary cancer consultation clinic. (5)
Familial polyposis coli and neurofibromatosis in the same patient: a family study. (5)
Heredity and colon cancer. (5)
Colorectal cancer survival advantage in MUTYH-associated polyposis and Lynch syndrome families. (5)
Breast cancer diagnosis in a putative obligate gene carrier. A family study. (5)
Lynch syndrome in South America: past, present and future (5)
Familial Pancreatic Cancer (4)
Genetics and Colorectal Cancer1 (4)
Colonoscopy in relation to the evolving genetics of familial colorectal cancer. (4)
The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. (4)
Common BRCA 2 Variants and Modification of Breast and Ovarian Cancer Risk in BRCA 1 Mutation Carriers (4)
The Relevance of the Family History of Cancer in a Screening Program for Large Bowel Tumors (4)
Conceptual differences on the occurrence of internal malignancies in the FAMMM syndrome. (4)
Genetics of rectal cancer. (4)
Recent progress in colorectal cancer : biology and management of high risk groups : proceedings of the 5th International Symposium on Colorectal Cancer : biology and management of high risk groups, Torino, 24-26 September 1991 (4)
Diethylstilbestrol, teratogenesis, and carcinogenesis: medical/legal implications of its long-term sequelae, including third generation effects. (4)
Erratum: Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus (American Journal of Human Genetics (2016) 98(6) (1082–1091) (S000292971630057X) (10.1016/j.ajhg.2016.03.022)) (4)
Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in CDH1 mutation carriers (4)
Cancer Frequency Variations Among and Within Families (4)
Ophira M. GinsburgCharmaine Kim-SingWilliam D. Foulkes • Parviz GhadirianHenry T. LynchPing SunSteven A. Narod • Hereditary Breast Cancer Clinical Study Group (4)
Cigarette Smoking and Breast Cancer Risk (4)
CEA and genetics (4)
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome (4)
The NIH Consensus Report on "Precursors to Malignant Melanoma". A different perspective. (4)
Hereditary factors in childhood cancer. (4)
Analysis of the CDKN2A Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers. (4)
In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees (4)
Genetic Counseling and Management of Newly Diagnosed Breast Cancer Patients at Genetic Risk for BRCA Germline Mutations (4)
Surveillance and management of hereditary breast cancer (4)
Is there a genetic predisposition to malignant mesothelioma (4)
Efficacy of proximal colectomy for surgical management of right-sided first colorectal cancer in Lynch Syndrome mutation carriers. (4)
Familial Cancer. Foreword. (4)
Familial sarcoma (4)
Genetic risk in ovarian cancer. (4)
[Prevention of colorectal carcinoma. Current WHO guidelines for early detection of colorectal carcinoma. World Health Organization Collaborating Center for the Prevention of Colorectal Cancer]. (4)
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers? (4)
A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families (4)
Stemming the tide of cancer for BRCA1/2 mutation carriers. (4)
Small, nonpolupoid colonic neoplasms (4)
HEREDITY AND THE MORE COMMON MALIGNANCIES OF MAN: CARCINOMA OF THE BREAST, STOMACH, COLON, LUNG, PROSTATE, AND ENDOMETRIUM (4)
Multiple HNPCC tumours: ask the family! (4)
Screening for hereditary colorectal cancer (4)
NAMING THE MELANOMA-PRONE SYNDROME (4)
Cellular immune function study in an ovarian cancer-prone kindred. (4)
Clues to cancer risk: biologic markers. (4)
Genetic counseling issues (4)
Cancer prevention, molecular genetics and hereditary cancer syndromes of colon and breast. (3)
Familial Cancer: Editorial (3)
Hepatic artery infusion: surgical approach. (3)
Genetics of Common Tumors (3)
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers (3)
Genetics, skin and cancer control. (3)
Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes. (3)
RESPONSE: Re: Familial Multiple Myeloma: a Family Study and Review of the Literature (3)
Cancer in southeast Asia. Strategies for control. (3)
Genetics and environment in Hodgkin's disease (3)
Regression of colorectal adenomas with intravenous cytotoxic chemotherapy in a patient with familial adenomatous polyposis. (3)
Foreword for “100 years of Lynch syndrome” (3)
Challenging colonic polyposis pedigrees: differential diagnosis, surveillance, and management concerns. (3)
A Comparison of Statistical Approaches for Genetic Anticipation with Application to Pancreatic Cancer (3)
For the Record: The History of Precursors to Malignant Melanoma-Reply (3)
Family information service (FIS) in a BRCA1 extended family. (3)
Bio-assay of Human Serum Parathormone-like Activity. (3)
Hereditary pancreatic cancer: Pedigree analysis of pancreatic cancer families (3)
Laterality of breast cancer in families. (3)
Medical-legal aspects of familial cancer. (3)
Is cancer communicable? (3)
Challenging pancreatic cancer-prone pedigrees: a nosologic dilemma (3)
Pros and cons of genetic screening for breast cancer. (3)
Genetic Epidemiology and the Familial Atypical Multiple Mole Melanoma Syndrome (3)
Hormone replacement therapy and the risk of ovarian cancer in BRCA 1 and BRCA 2 mutation carriers (3)
Microsatellite instability, disease-free survival and role of tumour infiltrating lymphocytes (Invited editorial on 'Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicenter study'). (3)
BRCA1 and BRCA2: to test or not to test (3)
Psycho-social factors in a family with a disfiguring genetic fault. (3)
Colorectal Cancer: Molecular and Cellular Abnormalities (3)
HLA in breast cancer-prone families and the cancer family syndrome. (3)
Hereditary Colon Cancer Syndromes and Their Surveillance/Management1 (3)
Serum and hair selenium levels in hereditary nonpolyposis colorectal cancer (3)
FAMILIAL SUSCEPTIBILITY TO LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (3)
Heredity, emotions and cancer control. (3)
Phenotypic Variation and Systemic Cancer in the FAMMM Syndrome (3)
Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family. (3)
A computer based system of coding for genetic studies of large kindreds. (3)
A questionnaire survey of Midwest dermatologists on the clinical-genetic aspects of patients with multiple atypical nevi. (3)
Historical Aspects of Lynch Syndrome (3)
Introduction to special issue of Familial Cancer (2)
Familial Atrioventricular Conduction Defect (2)
Melanoma and the atypical nevus. (2)
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer (2)
Total colectomy and the cancer family syndrome (2)
Abstracts Accepted for Plenary & Parallel Sessions 55th Annual Cancer Symposium Society of Surgical Oncology March 14–17, 2002 Denver, CO (2)
Therapeutic biomarker differences between MSI-H and MSS colorectal cancers. (2)
Familial polyposis coli: genetics, surveillance, and treatment. (2)
Heredity and colon cancer. Part VII. Prognosis in hereditary colon cancer. (2)
Challenging pedigrees seen in a hereditary cancer consultation center. (2)
The role of Creighton University’s hereditary cancer center (2)
Cancer variation associated with the position of BRCA2 gene mutation (2)
Historical and Natural Cancer History Facets of the Lynch Syndromes (2)
Breast Cancer Genetics1 (2)
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (2)
Familial pancreatic cancer (Part II): Surveillance, diagnostic tests, and surgical strategies. (2)
570PTHYMIDYLATE SYNTHASE OVER-EXPRESSION UNDERLIES THE OBSERVED LACK OF 5-FU THERAPY BENEFIT FOR MSI-H COLORECTAL CANCERS. (2)
PALATAL ABNORMALITIES IN HEREDITARY DISEASES. (2)
Hereditary colorectal cancer : proceedings of the Fourth International Symposium on Colorectal Cancer (ISCC-4), November 9-11, 1989, Kobe Japan (2)
Cancer resistance: I. (2)
The familial atypical multiple-mole melanoma syndrome and its associated risk for pancreatic cancer (2)
A demonstration project on cancer screening in rural Thailand: preliminary report. (2)
Cigarette Smoking and Breast Cancer Risk: Limited Evidence of Genotypic and Exogenous Carcinogenic Factors and Their Interactions (2)
Malignant Melanoma and Associated Cancer (2)
BRCA 1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA 1 GermLine Mutations 1 (2)
The delay problem in cancer. (2)
HEREDITY AND CARCINOMA (2)
The explosion of hereditary cancer knowledge: Benefiting from a family information service (2)
Overview and Epilogue (2)
Mammography Screening in Women Under Age 50 Years (2)
Genetic counseling of high-cancer-risk patients: jurisprudential considerations. (2)
Hereditary colon cancer syndromes: polyposis and nonpolyposis (Lynch syndromes I & II) variants (2)
Familial neuroendocrine tumors as a model of hereditary cancer. (2)
Lynch Syndrome II in a Navajo Family: A Revisit (2)
Familial Clustering of Plasma Carcinoembryonic Antigen (CEA) in the Cancer Family Syndrome (2)
Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer. (2)
GENETIC ANTICIPATION IN PANCREATIC CANCER: COMPARISON OF STATISTICAL TESTS (2)
Inactivation of E-cadherin in stomach cancers arising in the hereditary diffuse gastric cancer syndrome (2)
HEREDITY AND CARCINOMA (2)
Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part II) (2)
Concurrent Von Recklinghausen's neurofibromatosis, hereditary spherocytosis and fronto nasal dysplasia. (2)
Genetic counseling in cancer: a status report--part 2. (2)
Lynch Syndrome: Its Phenotypic and Genotypic Heterogeneity (2)
Glossary of key terms. (2)
The role of genetics and host factors in cancer susceptibility and cancer resistance (2)
Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (Family G of warthin) (2)
Prevalence of extra-esophageal cancers in patients with Barrett's esophagus and esophageal adenocarcinoma. (2)
Should Risk-Reducing Surgery in Women from Hereditary Breast Ovarian Cancer Families be Confined to Removal of the Fallopian Tubes with Ovarian Conservation? (2)
Commentary on Lynch syndrome and related familial colorectal cancers (1)
Atypical nevi and melanoma update at American Academy of Dermatology meeting, December 1986. (1)
Genetic Testing of Families With Hereditary Diseases-Reply (1)
Accurate classification of MLH1 (1)
Challenging pancreatic cancer-prone pedigrees: a nosologic dilemma (1)
Novel MSH2 Mutation in the First Report of a Vietnamese–American Kindred with Lynch Syndrome (1)
Familial aggregation of lung cancer and other pulmonary diseases (1)
Small, nonpolypoid colonic neoplasms. (1)
Endometrial and ovarian cancer risk-reducing surgery in women with lynch syndrome (1)
Medical students as "probation officers" for juvenile offenders. (1)
Dysplastic nevus syndrome. (1)
Change in serum dehydroepiandrosterone, testosterone, insulin-like growth factor-1, and osteocalcin levels with the third generation selective estrogen receptor modulator arzoxifene (LY353381·HCI) (1)
A medical and genetic critique of the familial atypical multiple mole melanoma syndrome and the dysplastic nevus syndrome. (1)
Mendelian Predisposition to Lymphomagenesis (1)
MEDICAL GENETICS IN NEBRASKA. (1)
Heredity and colon cancer. (1)
Involuntary Hospitalization And Bias Against Marginalized Groups (1)
Cancer and Genetic Counseling (1)
Colorectal Cancer in Rural Nebraska 1 (1)
Obstructive lung disease in hereditary alpha 1-antitrypsin deficiency. (1)
Heredity, cancer, and the genetics clinic. (1)
Lynch syndrome TACSTD1 family with predominant colorectal cancer. (1)
Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers (1)
Lay Volunteers and Mobile Multiphasic Cancer Screening (1)
Genetics of Colorectal Cancer (1)
P1039 HEREDITARY MIXED POLYPOSIS SYNDROME MAY BE ASSOCIATED WITH MUTATION IN THE BMPR1A GENE ON CHROMOSOME 10Q22.3 (1)
Diagnosing lynch syndrome in absence of colorectal cancer. (1)
Title: Lynch Syndrome in the 21 st Century: Clinical Perspectives (1)
Heredity and cancer. (1)
Biomarker studies in hereditary ovarian carcinoma. (1)
How early to test for a cancer-causing germline mutation. (1)
The impact of family information services on genetic testing uptake among relatives in Lynch syndrome families. (1)
Cancer genetics, genetic counseling, and cancer control. (1)
Hereditary breast cancer: Search for biomarkers (1)
Kluwer Academic PublishersFamilial Cancer (1)
Gene-environment interactions in hereditary nonpolyposis colorectal cancer: potentiation of colon cancer risk by tobacco use and HMLH-1 mutations (1)
MGUS, multiple myeloma, and paratarg-7. (1)
Delay: a problem in cancer control. (1)
Hereditary malignant melanoma--conceptual differences. (1)
Consideration of privacy and confidentiality in conducting family studies (1)
Immunochemical Biological Markers and Hereditary Cancer Risk (1)
Cancer genetics: surveillance and control. (1)
Weight Gain After Oophorectomy Among Women with a BRCA1 or BRCA2 Mutation (1)
GENETIC TESTING OF FAMILIES WITH HEREDITARY DISEASES. AUTHORS' REPLY (1)
Genetic aetiology of diffuse gastric cancer: so near, yet so far (1)
The Familial Atypical Multiple Mole Melanoma Syndrome and Visceral Cancer (1)
P0787 SAFETY AND EFFICACY OF CELECOXIB IN CHILDREN WITH FAMILIAL ADENOMATOUS POLYPOSIS (1)
The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. (1)
DOES GEOGRAPHIC VARIATION IN THE DISTRIBUTION OF APC GENE MUTATION ACCOUNT FOR PHENOTYPIC VARIATION IN FAMILIAL ADENOMATOUS POLYPOSIS?: 134 (1)
A Study of Five Cancer Families. (1)
COMPLETE TRANSPOSITION OF GREAT VESSELS. MANIFESTATION IN TWO SIBLINGS CONFIRMED AT AUTOPSY. (1)
Phenotypic variation in hereditary breast cancer. Cancer control implications. (1)
What can be done to Improve Uptake of Genetic Testing for Inherited Colorectal Cancer Susceptibility (1)
Klinefelter's syndrome and metastatic breast cancer (1)
Investigational strategies for detection and intervention in early-stage pancreatic cancer (1)
Compliance by High-Risk Women (1)
Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation (1)
Inherited Susceptibility to Cancer: Clinical, Predictive and Ethical Perspectives (1)
Stemming the tide of cancer for BRCA1 (1)
Familial plasma cell disorders and associated cancers. (1)
Host factors in cancer prevention (1)
FAMILIAL ADENOMATOUS POLYPOSIS IN CHILDREN UNDER 10; PRESENTATION AND CLINICAL OUTCOME: WHO GOES TO COLECTOMY?: 136 (1)
Genetic susceptibility testing (1)
Familial embryonal carcinoma in a cancer-prone kindred. (1)
The American founder mutation for Lynch syndrome: Prevalence and cancer control implications (1)
Genetic Basis of Cancer Syndromes (1)
Therapeutic and Preventive Implications of Moonshot in Hereditary Cancer Syndromes. (1)
Familial Carcinoma of Unknown Primary. (1)
Familial Heterogeneity of Breast Cancer Risk (1)
Clinical Importance of Familial Cancer1 (1)
A Founder Mutation of theMSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States (1)
Video Capsule Endoscopy: What Is the Role in Surveillance of Hereditary Colon Cancer Syndromes? (1)
Breast cancer and the use of oral contraceptives. (1)
Hereditary Factors in Endometrial Cancer (1)
Cancer families, a hereditary cancer syndrome. (1)
Gene-environment interactions in hereditary nonpolyposis colorectal cancer: potentiation of colon cancer risk by tobacco use and HMLH-1 mutations (0)
Lynch Syndrome and the Role of the Registered Nurse: Commentary on “Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses” (0)
Medical/Legal Concerns in the Management of Patients from Lynch Syndromes Kindreds (0)
Hereditary Breast Cancer: Mutations Within BRCA1 and BRCA2 with Phenotypic Responses (0)
Phenotypic Variation in Hereditary Breast Cancer (0)
Genetic counseling (a scientific exhibit). (0)
Classical Examples of Heredity and Malignancy (0)
Genetic counseling. (0)
Hereditary diffuse gastric cancer in the developing world: A Jordanian family. (0)
Lifetime Colonic Polyp Rate Comparisons and the EPCAM Deletion (0)
Familial Cancer: Introduction (0)
Regression of colorectal adenomas with intravenous chemotherapy in a patient with familial adenomatous polyposis. (0)
Familial cancer syndromes (0)
Recent Progress in Cancer Family Syndrome. (0)
Hyperphosphorylation of Antigenic Targets of Paraproteins In MGUS and Multiple Myeloma (MM) Is a Consistent Finding: Implications for the Pathogenesis of MGUS/MM (0)
letter to the editor (0)
Oncogenetics and Interdisciplinary Collaborations: Essential for Progress (0)
Erratum to: A new hereditary colorectal cancer network in the Middle East and eastern Mediterranean countries to improve care for high-risk families (0)
Vitamin D-Intoxicated Patient With (0)
Hereditary colorectal cancer and brain tumor syndromes (0)
Where R.N.s run a mobile cancer-detection unit. (0)
Cancer Genetics (0)
AN INTERNET BASED PEDIATRIC RESIDENT QUESTIONNAIRE ON KNOWLEDGE ON HEREDITARY GASTROINTESTINAL POLYPOSIS SYNDROMES: 135 (0)
Melanocytic dysplasia and internal malignancy (0)
Table 3. [Percentage of Persons with CRC...]. (0)
Abstract 2300: Deleterious germline mutations in theBRCA1gene are associated with increased risk for cancers of the female reproductive system other than breast and ovarian as well as other cancers (0)
Integration of family history and medical management of patients with hereditary cancers (0)
New Series to Explore Cancer Genetic Issues (0)
Incidence of early-onset multiple myeloma among families with endometrial carcinoma. (0)
Other Cancers with Familial Clusterings (0)
The flat adenoma: Significance and management (0)
Attenuated familial adenomatous polyposis: association of age and polyp characteristics with colorectal cancer (0)
A novel mutation in hMLH1 gene in a Uruguayan Hereditary non-polyposis colorectal cancer (HNPCC-Lynch syndrome) family. (0)
CAPP2: a randomised chemoprevention trial of aspirin and resistant starch in Lynch Syndrome (0)
The Rubinstein et al Article Reviewed (0)
Abstract 1924: The paraproteins of patients with familial MGUS / multiple myeloma (MM) target family-specific antigens: Experience with paratarg-7 and paratarg-8 (0)
Heredity and Cancer Control: Genetic Counseling. (0)
BIOMARKERS AND COLORECTAL CANCER GENETICS: LYNCH SYNDROMES I AND II (0)
Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry (0)
Paramedical role in a multiphasic mobile cancer screening unit (0)
Invited editorial (0)
Update in Cancer Genetics: Clinical translation - Foreword (0)
CHAPTER 2 CLASSICAL EXAMPLES OF HEREDITY AND MALiGNANCY (0)
Cáncer gástrico difuso hereditario: implicaciones para la oncología quirúrgica profiláctica (0)
Extracolonic Manifestations of Familial Adenomatous Polyposis After Proctocolectomy—Invited Critique (0)
Skin, genetics, and cancer a trilogic approach to cancer control. (0)
Southwestern Athabaskan genetic diseases. (0)
My specialty: cancer genetics. (0)
KLHDC8B Is a Novel, Mitotically-Regulated Classical Hodgkin’s Lymphoma Candidate Susceptibility Gene. (0)
Hereditary colorectal carcinoma syndromes and their implications for colorectal carcinoma in Puerto Rico. (0)
Inherited, Familial andSporadic Primary Open-Angle Glaucoma (0)
Molecular screening, genetic counseling, and cancer prevention: Lynch syndrome as a model (0)
Patients with Familial Adenomatous Polyposis and Identified APC Gene Mutations Associated with Turcotʼs Syndrome – Necessity of CNS Tumor Surveillance?: 515 (0)
GENETIC COUNSELING. (0)
Creighton University to open hereditary cancer prevention clinic. (0)
Identification of new susceptibility genes in familial breast cancer by exome sequencing. (0)
Genetics and cancer in children. (0)
THE LYNCH SYNDROME: NATURAL HISTORY WITH SURVEILLANCE AND MANAGEMENT IMPLICATIONS (0)
Pancreatic cancer risk in BRCA2 mutation carriers extends beyond first degree relatives (0)
Cancer genetics: urological system. II. (0)
Lynch syndrome founder mutations in families of Navajo and German-American heritage. (0)
W1401 Dose-Dependent Effects of Alcohol and Tobacco On Age of Presentation in Pancreatic Cancer (PC): A Multicenter, International Study (0)
The life and death of medical records. (0)
Table 4. [Selected MUTYH Pathogenic Allelic Variants]. (0)
History of Cancer Genetics in Man (0)
Familial Breast and Colorectal Cancer (0)
Cellular Immune Response in Lynch Syndrome II on Gastrointestinal Biopsy (0)
Lynch Syndromes I and II - Natural History, Diagnosis and Control Strategies (0)
The long term impact of resistant starch on cancer risk in carriers of hereditary colorectal cancer:the CAPP2 Randomised Controlled Trial (0)
Acquired nonfamilial melanoma: an inappropriate conclusion. (0)
Concordant and discordant cancers in familial atypical multiple mole melanoma syndrome (FAMMM) with the CDKN2A mutation (0)
Advances in Brief Genetic Instability of Microsatellites in Endometrial Carcinoma (0)
Clinicopathologic and Genetic Studies of the Lynch Syndromes and Familial Nonpolyposis Colorectal Cancer: An Update with Screening Recommendations1 (0)
Familial myeloma - Reply (0)
DNA screening for cancer susceptibility (0)
Epidemiology and Carcinogenesis of Rectal Cancer (0)
Congenital Cancer and Congenital Abnormalities Associated with Cancer (0)
Subject Index, Vol. 2, 1984 (0)
Proteomic analysis of BRCA-1 breast cancer, BRCA-1 carriers and sporadic breast cancer (0)
Colorectal Cancer: From Pathogenesis to Prevention (0)
Breast Cancer Genetics: Syndromes, Genes, Pathology, Counseling, Testing, and Treatment (0)
Cancer genetics: strategies for preventive oncology. (0)
Breast cancer and importance of zygosity determination in triplet sisters (0)
Short stature and language delay in a 5-year-old girl: 18p- syndrome. (0)
News and notices (0)
Medical genetics, Huntington's chorea, and legal questions pertaining to autopsy. (0)
Cancer genetic. 3. Genetic markers, childhood cancer problems. (0)
Cancer resistance. II. Cancer variations in families in a normal population. (0)
Hereditary breast and ovarian cancer: lessening the burden. (0)
Contributors (0)
511e: Screening for Barrett'S in High Risk Families: Is It Worthwhile? (0)
The role of prophylactic surgery for hereditary breast and ovarian cancer (0)
Teaching comprehensive medicine in the home setting: a preliminary report. II. (0)
Genetics and medical emergencies: an interesting patient. (0)
Effect of hierarchical clustered sampling in multicenter, family-based studies: Example of reproductive history and breast cancer risk in BRCA1 mutation carriers. (0)
CHAPTER 1 HISTORY OF CANCER GENETICS IN MAN (0)
Heredity and colon cancer. Part III. Gardner's syndrome. (0)
EDITORIALS Prophylactic Mastectomy: Obstacles and Benefits (0)
Erratum: Smoking and the risk of breast cancer among carriers of BRCA mutations (International Journal of Cancer (2004) 110 (413-416)) (0)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (0)
Ultimately, It Matters Where, When, and What They'll Meet (0)
Prostate Cancer Genetics in African Americans (0)
Riskandsurveillance ofindividuals withheritable factors forcolorectal cancer (0)
Helicobacter pylori and Gastroduodenal Secretory Function (0)
APC GENE MUTATIONS ASSOCIATED WITH TURCOT'S SYNDROME IN CHILDREN WITH FAMILIAL ADENOMATOUS POLYPOSIS: OPPORTUNITIES FOR TUMOR SURVEILLANCE? (0)
Rare alleles of the HRAS polymorphism do not modify the risk of breast or ovarian cancer in BRCA1 carriers (0)
Complementation Group C and Malignant Melanoma (0)
Progress in clinical and research oncogenetics: Hereditary colon, breast, and pancreatic cancer (0)
EDITORIALS Microsatellite Instability, Clinical Implications, and New Methodologies (0)
Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6. (0)
Detecting BRCA2 protein truncation in breast tissue biopsies to identify hereditary cancer. (0)
Environment and genes in the development of colorectal cancer. (0)
Prophylactic cranial irradiation: going, going, gone (0)
Cancer genetics. I. Historical background and animal studies. (0)
Hereditary Disorders with Variable Malignant Neoplastic Predisposition (0)
Genetics and cancer control: identification of high risk patients (0)
Advances in Brief HMSH 2 Mutations in Hereditary Nonpolyposis Colorectal Cancer Kindreds 1 (0)
Wilms' Tumor, Congenital Heart Defects, Pheochromocytomas and Thyroid Cancer-Reply (0)
Genetic Counseling Using BRCA1-Linked Markers (0)
Clinical patterns and heredity of the FAMMM syndrome: 45 (0)
Primary choroidal andcutaneous melanomas, bilateral choroidal melanomas, andfamilial occurrenceof melanomas (0)
Mammography and hereditary breast cancer (0)
Cancer genetics in women. Volume I (0)
Colonoscopy Findings in a Series of Patients with Hereditary Colorectal Cancer (0)
750 Identification of Inherited Predisposition to Colonic Neoplasia Through Partial Wave Spectroscopic Analysis of the Microscopically Normal Colonic Epithelium (0)
Quality indicators for colonoscopy and the risk of interval cancer. (0)
Epidemiologic Linkage: Diet, Genetics, and Cancer (0)
Book Review The Third Conference on the Clinical Delineation of Birth Defects, Part X: The endocrine system: Held at Johns Hopkins Hospital, June 15–19, 1970. Edited by Daniel Bergsma, M.D. 330 pp., illustrated. Baltimore: Williams and Wilkins, 1971. $20.75. (0)
Hereditary Malignant Melanoma and the Fammm Syndrome (0)
Invited commentary (0)
Hereditary breast cancer: Shared communication and care. Authors' disclosures (0)
Crypt Atrophy of Colorectal Mucosa in Lynch Syndromes I and II: Its Characteristics and Meaning, Preliminary Observations (0)
Workshop on Chemoprevention of Breast Cancer1 (0)
Variation in cancer risk among families with genetic susceptibility (0)
A note on cancer control. (0)
Cancer and heredity: implications for early cancer detection. (0)
Contents, Vol. 2, 1984 (0)
Genetic Disorders Associated with Exocrine and Endocrine Pancreatic Tumors (0)
Invited editorial (0)
Nonsteroidal Anti-Inflammatory Drugs (NSAID) and Colorectal Cancer (0)
Table 1. [Molecular Genetic Testing Used in MUTYH-Associated Polyposis]. (0)
Penetrating the information maze. (0)
Determining familial risk of multiple myeloma (0)
Cancer genetics. II. Studies in humans. Problems in human studies. (0)
Re: Familial multiple myeloma: A family study and review of the literature - Response (0)
INTROGENIC HYPOTHYROIDISM IN A PATIENT WITH TURNER'S SYNDROME (0)
Report on a Pair of Male Monozygotic Twins Concordant for Schizophrenia (0)
Cancer genetics: urological system. Part I. (0)
Deletions Led to the Identification of Four New BRCA 1 Mutations in Screening for GermLine Rearrangements and Regulatory Updated Version (0)
Heredity and colon cancer. Part II. Polyposis coli syndromes. (0)
Title Novel MSH 2 Mutation in the First Report of a Vietnamese-American Kindred with Lynch Syndrome (0)
Commentary: The shifting role of family history in Lynch syndrome diagnosis (0)
Lifetime Polyp Rate Comparisons and the EPCAM Deletion (0)
Rare diseases of the digestive system (0)
Index to Books Reviewed (0)
Volume Contents (0)
NATURE VS NURTURE; DISEASE EXPRESSION IN JUVENILE POLYPOSIS SYNDROME MAY BE INFLUENCED BY EXOGENOUS FACTORS AND COMORBID DISEASE: 137 (0)
Cancer genetics, genetic counseling, and cancer control. Part II. (0)
Genetic predictability in certain forms of cancer. (0)
Cancer genetics, part III: genetic markers, childhood cancer problems (0)
Breast cancer,genetics, andageatfirst pregnancy (0)
First report of a family with Lynch syndrome type II in Puerto Rico. (0)
Family Chronicles of Missed Opportunities. (0)
Contents Volume 4 (0)
Letter: Malignant melanoma and associated cancer. (0)
Mo1739 - Risk of Gastric Cancer in Lynch Syndrome Persists in U.S. Families (0)
675 Unveiling of DNA Repair Gene Alterations in Non-Lynch Hereditary Colorectal Cancer Through Exome Sequencing (0)
Author reply (0)
Psychodynamics in a Chronic Debilitating Hereditary Disease (0)
PAST, PRESENT, AND FUTURE OF HNPCC (0)
Familial pancreatic cancer: Insight into etiology or an interesting quirk of nature? (0)
In Memoriam: Dr. Enrique Pimentel (0)
Keratoacanthomas associated with cervical squamous cell carcinoma. (0)
Commentary on 'Colonoscopy screening compliance and outcomes in patients with Lynch syndrome'. (0)
184 – Cancer Genetics (0)
Letter: Lay volunteers and mobile multiphasic cancer screening. (0)
Phenotypic variations in hereditary diseases with implications for genetic counseling: a family with congenital heart and skeletal anomalies. (0)
Hereditary Aspects of some Less Frequently Occurring Malignancies Exclusive of the Reticuloendothelial System (0)
Cancer and you (0)
Identification of BRCA1 and BRCA2 genetic modifiers. (0)
Heredity and Malignancies of The Reticuloendothelial System (0)
Familial Aggregation in Genetic Studies of Primary Open–Angle Glaucoma (0)
Heredity and colon cancer. Part IV. (0)
Impact of BRCA mutation test results in members of hereditary breast ovarian cancer (HBOC) families (0)
The Cutaneous Manifestations of the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome (0)
Inherited Syndromes in Gastrointestinal Cancers (0)
Iatrogenic hypothyroidism in a patient with Turner's syndrome. (0)
Prevalence of PALB2 mutations in the Creighton University breast cancer family registry. (0)
Precursors to Malignant Melanoma-Reply (0)
Use of the Lectin from Amarant hus cautiat us as a Histochemical Probe of Proliferating Colonie Epithelial Cells 1 (0)
Teaching comprehensive medicine in the home setting: a preliminary report. I. (0)
Table 2. [Biallelic Germline MUTYH Pathogenic Variant...]. (0)
Function Factor II Expression in Breast Stroma : Evidence for Paracrine Malignant Breast Epithelium Selects for Insulin-like Growth Updated (0)
CHRPE in non-Gardner's familial polyposis coli patients. (0)
Free Paper (0)
Historical development of Lynch syndrome (0)
Screening for colorectal cancer: ask about the family (0)
P0015 PP BETA CATENIN IMMUNOHISTOCHEMISTRY IN SYNDROMIC COMPARED TO SPORADIC JUVENILE POLYPS (0)
The life and death of medical records. (0)
FIS impact upon BRCA testing uptake and prophylactic oophorectomy/mastectomy among HBOC attendees (0)
Abstract P3-08-08: Preferences for breast cancer risk reduction amongBRCA1andBRCA2mutation carriers: A discrete choice experiment (0)
Conclusions — Future Directions (0)
The Medical Bookshelf. (0)

This paper list is powered by the following services:

Other Resources About Henry T. Lynch

en.wikipedia.org

What Schools Are Affiliated With Henry T. Lynch?

Henry T. Lynch is affiliated with the following schools: